A Phase 3 Study Comparing the Effects of Subcutaneous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin
Clinical trial NCT01473420 · COMPLETED
Trial details
- NCT number
- NCT01473420
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-17
- Primary completion
- 2014-02-28
- Enrollment
- 320
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.